Search

Author/Creator Taningco, Lilia

1. Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial. Issue 1 (19th July 2022)

Authors:
Casulo, Carla; Santoro, Armando; Cartron, Guillaume; Ando, Kiyoshi; Munoz, Javier; Le Gouill, Steven; Izutsu, Koji; Rule, Simon; Lugtenburg, Pieternella; Ruan, Jia; Arcaini, Luca; Casadebaig, Marie‐Laure; Fox, Brian; Kilavuz, Nurgul; Rettby, Nils; Dell'Aringa, Justine; Taningco, Lilia; Delarue, R...
Journal:
Cancer reports
Issue:
Volume 6:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial. Issue 5 (May 2015)

Authors:
Blay, Jean-Yves; Shen, Lin; Kang, Yoon-Koo; Rutkowski, Piotr; Qin, Shukui; Nosov, Dmitry; Wan, Desen; Trent, Jonathan; Srimuninnimit, Vichien; Pápai, Zsuzsanna; Le Cesne, Axel; Novick, Steven; Taningco, Lilia; Mo, Shuyuan; Green, Steven; Reichardt, Peter; Demetri, George D
Journal:
Lancet oncology
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
550
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search